EnhydrisPECorp
EnhydrisPECorp
Send Message
EnhydrisPECorp
Stop FollowingEnhydrisPECorp
View as an RSS Feed
View EnhydrisPECorp's Articles BY TICKER:
- Still Bullish On Apple - But For How Long?
- Vringo's Catalyst Is Finally At Hand, Or Is It?
- Bulls On Parade: Is Nanosphere's Bull Run Over?
- Arena Is Still A Great Short
- Amarin: It's The Strategy, Not The Science
- Anacor Pharmaceuticals: Should Retail Follow Institutions On This Biotech?
-
Belviq's Sales Will Disappoint: Demographics Matter
- Why I Am A Biotech Permabull
- Generalist Vs. Specialist Approaches In The Competitive Pharmacy Space
- Stem Cells: Invest At Your Own Peril
- 2 Undiscovered Patent Plays: Will History Repeat Itself In The Patent Infringement Space?
- Stem Cells: Dreamers, Fools, And The Valley Of Death
- Darwinian Selection In Medical Devices: Brachytherapy Offers Investors Hope
- Investing In The Stem Cell Sector: An Overview
- This Biopharma Is Ready To Be Shorted
- Dara Biosciences: Don't Believe The Hype Surrounding This Biopharma
- The Arena Conspiracy And DEA Scheduling
- Inovio's Hepatitis C Data: What Does It Really Mean?
- Does This Hot Biotech Still Have Legs Or Is It Time To Take Profits?
- Will AMR-001 Lead Neostem To The Promised Land?
- Is This Biotech A Value Stock Or Value Trap?
- Advaxis Vs. Inovio: A Head To Head Comparison Of 2 Cervical Cancer Vaccines
- Can The NTP Lawsuit Provide Insight Into Vringo's Ongoing Battle With Google?
- NewLink Genetics Corporation: A Promising Immunotherapy Company With An Upcoming Catalyst
- Keryx Biopharmaceuticals: Time To Get Short
- Biolase A Strong Value Buy In The Biotech Space
-
Inovio Pharmaceuticals: The Risks Outweigh The Rewards
- Sangamo BioSciences: A Biotech Not To Be Shorted
- Is It Time To Go Long Or Short Telik?
- 2 Biotech Short-Squeeze Candidates For The New Year
- Why Arena Pharmaceuticals Will Underperform In 2013
- Herbalife: Value Pick Or Short Candidate?
